Biochemical modulation of 5-fluorouracil by PALA: mechanism of action.
Martin
D S
DS
Memorial Sloan Kettering Cancer Center, Cornell University Medical College, New York, NY.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
D007155:Immunologic Factors; D001224:Aspartic Acid; C013195:sparfosic acid; D010746:Phosphonoacetic Acid; D005472:Fluorouracil